Skip to main content
. 2018 Jun 5;293(29):11574–11588. doi: 10.1074/jbc.RA118.002062

Figure 2.

Figure 2.

Pharmacodynamic and pharmacokinetic properties of BPN-14136 in mice. Plasma RBP4 levels in CD-1 mice following a single 5 mg/kg oral (A) and a single 2 mg/kg intravenous (B) administration of BPN-14136 are shown. Plasma compound levels following administration of a single oral 5 mg/kg dose (C) and a 2 mg/kg intravenous dose (D) of BPN-14136 are shown. Data are represented as the mean ± S.D. Three mice per each time point of blood collection were used in the study.